Explorer

Bristol-Myers Squibb, Syngene International expand ongoing research collaboration

Bengaluru (Karnataka) [India], Nov 14 (ANI): To undertake a greater range of scientific research and development for pharmaceuticals across a broader range of activities, Syngene International, India's contract research organization, has announced that it has expanded its ongoing collaboration with Bristol-Myers Squibb.

The next phase of the partnership will see the addition of a new facility to support future Bristol-Myers Squibb research and development operations, an expansion of the team and the extension of the existing agreement through 2026.

Syngene and Bristol-Myers Squibb have worked together since 1998. The research campus, known as Biocon BMS Research Center (BBRC), Syngene's first dedicated R&D Center, was established in 2007, which was subsequently renewed through 2020 and now has been further extended through 2026.

It is the largest research and development facility for Bristol-Myers Squibb outside of the United States and plays an integral part within their global research and development network.

Since its inception, BBRC has contributed to the discovery and pre-clinical development of numerous drug candidates for further study, as well as generated data that has led to multiple patent filings around the world.

It has also played a key role in reducing the time and costs associated with advancing new compounds to first-in-human studies for Bristol-Myers Squibb.

As part of the expansion, Syngene will set up a new dedicated facility spread across 25,000 sq. ft. of laboratory and office space for Bristol-Myers Squibb. This facility will house an additional team of 75 Syngene scientists who will work exclusively in support of Bristol-Myers Squibb.

"We are proud of how the partnership with Syngene and the BBRC has evolved" said Carl Decicco, Ph.D., Head of Discovery, Bristol-Myers Squibb. "At its inception, it was thought that BBRC would be a fast, nimble organization that could partner closely with our R&D organization to accelerate the development of Bristol-Myers Squibb's pipeline and the partnership has exceeded all expectations."

Commenting on the extension of collaboration, Jonathan Hunt, Chief Executive Officer, Syngene International, said, "We are very excited about the potential that this expansion to our collaboration with Bristol-Myers Squibb brings in delivering innovative scientific solutions to address disease globally. We consider our work with Bristol-Myers Squibb to be a "flagship" relationship. They understand and appreciate the exceptional quality of science that is accessible at Syngene, and have been consistently generous in sharing their own expertise to nurture young Indian talent for the betterment of the collaboration and for patients everywhere."

BBRC provides integrated services supporting Discovery, Translational Sciences and Product Development functions for Bristol-Myers Squibb. (ANI)


This story has not been edited. It has been published as provided by ANI

View More
Advertisement
Advertisement
25°C
New Delhi
Rain: 100mm
Humidity: 97%
Wind: WNW 47km/h
See Today's Weather
powered by
Accu Weather
Advertisement

Top Headline

PM Modi Calls Congress A 'Bully' After Lawyers Write To CJI. Here's What He Said
PM Modi Calls Congress A 'Bully' After Lawyers Write To CJI. Here's What He Said
Actor Govinda Joins Eknath Shinde's Shiv Sena, Likely To Contest From Mumbai North West
Actor Govinda Joins Eknath Shinde's Shiv Sena, Likely To Contest From Mumbai North West
Sanjiv Bhatt Gets 20 Years In Jail Day After Conviction In 1996 Drug Seizure Case
Sanjiv Bhatt Gets 20 Years In Jail Day After Conviction In 1996 Drug Seizure Case
Kejriwal To Stay Delhi CM From Jail As High Court Finds 'No Legal Bar,' Ball In LG's Court Now
Kejriwal To Stay Delhi CM From Jail As High Court Finds 'No Legal Bar,' Ball In LG's Court Now
Advertisement
for smartphones
and tablets

Videos

Bihar Lok Sabha Polls 2024: ABP Exclusive With Papu Yadav, MP No Longer Contesting From PurniaVarun Gandhi Pens Emotional Letter To Pilibhit After Being Denied, Says 'Mai Aapka Hu Aur Rahunga'Delhi Excise Policy Case: With CM Arvind Kejriwal's Arrest, Who Will Run The State | Watch ReportLok Sabha Elections 2024: 'BJP Just Wants To Break The Aam Aadmi Party' says Saurabh Bhardwaj
Embed widget